AlphaYouSS
Insider selling
Sheldon Sloan sold $731K of Spyre Therapeutics, Inc. (SYRE) stock
Sheldon Sloan, Chief Medical Officer of Spyre Therapeutics, Inc. (SYRE), sold 8,334 shares of SYRE stock worth $731K, per an SEC Form 4 filed Jul 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 1, 2026, 2 days before it was made public.
SYRE has moved +3.5% since the trade date, from $88.89 to $92.03 (Sep 21, 2026 close).
- Traded
- Jul 1, 2026
- Disclosed
- Jul 3, 2026
- Filing delay
- 2 days
- Price since
- +3.5%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More SYRE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.